Shandong basic pharmaceutical centralized procurement bid price lower than the guide price drop 63.51%

Business News Agency February 28th According to Voice of China’s “Guangguang News” report, the first batch of companies and product prices for centralized procurement of essential medicines in Shandong Province was recently closed. The price of the 454 products to be awarded was lower than the retail price of the National Development and Reform Commission by 63.51. This is also the biggest reduction in the purchase price of basic medicines in the country so far.

In the three major stages of declaration of basic pharmaceuticals centralized purchasing subsidiaries, evaluation of economic and technological tenders, and bidding for commercial bids in Shandong Province, the reporting companies were first reviewed and reviewed by the expert group, and after screening, 6,378 products of 975 companies that met the qualification criteria were re-used. Envelope system, based on the principle of one species, one specification, and one price, "three ones," simultaneously invested in economic and technical tenders and business tenders. A total of 643 declared enterprises and 3048 specifications passed the review of economic and technological tenders and entered. The evaluation of the business tenders was conducted on the Internet remotely and the lowest bidder was awarded the bid. Compared with other provinces, Shandong Province for the first time centralized purchasing by the province as a unit, no longer divided into regions, one-time completion of the entire procurement process, to minimize intermediate links and reduce procurement costs. Wang Aijie, director of the Shandong Drug Centralized Procurement Center, explained that the single source of promise is a relatively large amount of attractiveness to the enterprise because the quantity and price are linked, and the quantity brought about is the low price.

The products won the bid will be distributed directly to all retail pharmacies and government-run primary-level medical and health institutions according to the scope of diagnosis and treatment and service functions. Zero-difference sales will be implemented according to the purchase price, and all will be included in basic medical insurance drug reimbursement. Contents, reimbursement ratio is significantly higher than non-essential drugs.

At the same time, we have established a strict record of integrity and market retreat, and clarified measures to punish illegal companies. Six kinds of violations of drug companies and their legal persons are recorded on the record, and one violation is given a warning and ordered to be corrected or rectified within a time limit. If the deadline is not changed or the violation is repeated, the purchase of any medicines in Shandong Province shall not be undertaken within 2 years. Through strict punishment measures, the company will avoid malicious bids by the company and step out of the vicious circle of “price cuts” for drugs to ensure the supply of successful drugs.